Study finds lesions may compromise heart rate in Gilenya....

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Study finds lesions may compromise heart rate in Gilenya....

Post by MSUK » Mon Jul 20, 2015 6:43 am

Study finds lesions may compromise heart rate in Gilenya patients

In a recent study published in the Journal PLOS One, a team of researchers found that the autonomic cardiovascular dysfunction in MS patients with delayed heart rate re-acceleration upon Gilenya-initiation suggest MS-related central autonomic lesions may compromise heart rate re-acceleration..... Read More - http://www.ms-uk.org/gilenya
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post